BCTXL Financial Model

Quarterly and annual income statement, cash flow and balance sheet line items for BriaCell Therapeutics Corp. Warrant expiring 2031: revenue, gross and operating margin, EBITDA, free cash flow, buybacks, cash, debt and shares outstanding.

BCTXL – BriaCell Therapeutics Corp. Warrant expiring 2031 stock overview